Cargando…
Translational strategy using multiple nuclear imaging biomarkers to evaluate target engagement and early therapeutic efficacy of SAR439859, a novel selective estrogen receptor degrader
PURPOSE: Preclinical in vivo nuclear imaging of mice offers an enabling perspective to evaluate drug efficacy at optimal dose and schedule. In this study, we interrogated sufficient estrogen receptor occupancy and degradation for the selective estrogen receptor degrader (SERD) compound SAR439859 usi...
Autores principales: | Besret, Laurent, d’Heilly, Sébastien, Aubert, Cathy, Bluet, Guillaume, Gruss-Leleu, Florence, Le-Gall, Françoise, Caron, Anne, Andrieu, Laurent, Vincent, Sylvie, Shomali, Maysoun, Bouaboula, Monsif, Voland, Carole, Ming, Jeffrey, Roy, Sébastien, Rao, Srinivas, Carrez, Chantal, Jouannot, Erwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324464/ https://www.ncbi.nlm.nih.gov/pubmed/32601772 http://dx.doi.org/10.1186/s13550-020-00646-w |
Ejemplares similares
-
AMEERA-1 phase 1/2 study of amcenestrant, SAR439859, in postmenopausal women with ER-positive/HER2-negative advanced breast cancer
por: Bardia, Aditya, et al.
Publicado: (2022) -
Safety of Maternal Immunization Against Pertussis: A Systematic Review
por: D’Heilly, Caroline, et al.
Publicado: (2019) -
Immunological and Clinical Benefits of Maternal Immunization Against Pertussis: A Systematic Review
por: Switzer, Charlotte, et al.
Publicado: (2019) -
Characteristics of antibiotic exposures for surgical procedures prior to Clostridioides difficile diagnosis—Minnesota, 2018
por: D’Heilly, Paige, et al.
Publicado: (2022) -
Phase 1 study of oral selective estrogen receptor degrader (SERD) amcenestrant (SAR439859), in Japanese women with ER-positive and HER2-negative advanced breast cancer (AMEERA-2)
por: Tamura, Kenji, et al.
Publicado: (2023)